Inhibition of tumor growth by a truncated and soluble form of melanotransferrin
- 1 August 2007
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 313 (13) , 2910-2919
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivoBiochemical and Biophysical Research Communications, 2007
- In vivo inhibition of angiogenesis by a soluble form of melanotransferrinCarcinogenesis, 2006
- Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: A key phenomenon for cell invasionExperimental Cell Research, 2005
- Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic systemBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migrationBlood, 2003
- Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell MigrationJournal of Biological Chemistry, 2002
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- The Effect of Surgical Treatment on Survival from Early Lung CancerChest, 1992
- Angiogenic FactorsScience, 1987
- Human melanoma-associated antigen p97 is structurally and functionally related to transferrinNature, 1982